Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03829267 · ClinicalTrials.gov registry record · NA
eFIT: An Internet-based Intervention to Increase Physical Activity in Persons With MS
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT03829267: Completed NA study, sponsored by Columbia University.
NCT03829267 is a NA study that has completed, run by Columbia University. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03829267, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
eFIT is a technology-enabled internet based psychosocial intervention to increase physical activity in persons with multiple sclerosis, who are at unique risk for sedentary behaviors and for whom exercise and physical activity hold many benefits.
Primary Outcome
Assess feasibility of the program: Acceptability of intervention based on attendance rates of participants meeting the criteria of attendance at two-thirds of the meetings over 12-weeks
Interventions
- BEHAVIORAL Treatment as usual
- BEHAVIORAL eFIT Intervention
- BEHAVIORAL eJournal Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-04-26 |
| Est. Completion | 2020-04-13 |
| Phase | NA |
What the finished NCT03829267 record still lists
NCT03829267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Treatment as usual is the first listed.
NCT03829267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03829267 about?
NCT03829267 is a clinical study titled "eFIT: An Internet-based Intervention to Increase Physical Activity in Persons With MS". eFIT is a technology-enabled internet based psychosocial intervention to increase physical activity in persons with multiple sclerosis, who are at unique risk for sedentary behaviors and for whom exercise and physical activity hold many benefits.
What is the current status of trial NCT03829267?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2019-04-26. Estimated completion is 2020-04-13.
What interventions are being tested in trial NCT03829267?
The interventions under investigation include: Treatment as usual (BEHAVIORAL), eFIT Intervention (BEHAVIORAL), eJournal Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03829267?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03829267's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI